Shape Therapeutics logo

Shape Therapeutics

startupfundraising.com

Shape Therapeutics develops programmable RNA medicines that use AI and RNA technology to address genetic causes of disease. Its work includes RNA editing, next-generation AAV delivery and gene therapy manufacturing for pharmaceutical innovators developing treatments for rare genetic disorders and other diseases.

Facts

HQ
Seattle, Washington, US
Sectors
Biotechnology Research
Founded
2018
Type
Corporation Seattle business license
Employees
51–200
Registered name
Shape Therapeutics Inc Seattle business license
Stage
Series B

Is this your organization? Claim it

Members see Shape Therapeutics's funding rounds, amounts and investors.

People

  • David Huss Executive, Chief Scientific Officer and Interim CEO
  • Francois Vigneault Former founder

Online